Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duncan Richards

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Endocrinology|June 3, 2017
Mutant Mice With Calcium-Sensing Receptor Activation Have Hyperglycemia That Is Rectified by Calcilytic TherapyValerie N Babinsky, Fadil M Hannan, Reshma D Ramracheya, et al.
The Lancet. Respiratory Medicine|July 12, 2021
Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trialTimothy S C Hinks, Lucy Cureton, Ruth Knight, et al.
BMJ Open|June 23, 2024
PERI-operative biologic DMARD management: Stoppage or COntinuation during orthoPaEdic operations (the PERISCOPE trial) - a study protocol for a pragmatic, UK multicentre, superiority randomised controlled trial with an internal pilot, economic evaluation and nested qualitative studySamantha Brady, Andrew Mott, Katie Carlisle, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|April 20, 2022
Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trialJienchi Dorward, Ly-Mee Yu, Gail Hayward, et al.
The Lancet. Respiratory Medicine|December 19, 2021
Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trialBenjamin A Fisher, Tonny Veenith, Daniel Slade, et al.
Diabetes|November 21, 2007
Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese menUlf Risérus, Dennis Sprecher, Tony Johnson, et al.
Surgery|June 29, 2021
Multiple endocrine neoplasia type 1 in children and adolescents: Clinical features and treatment outcomesOmair A Shariq, Kate E Lines, Katherine A English, et al.
BMC Cardiovascular Disorders|February 14, 2022
Pharmacodynamic evaluation and safety assessment of treatment with antibodies to serum amyloid P component in patients with cardiac amyloidosis: an open-label Phase 2 study and an adjunctive immuno-PET imaging studyAshutosh Wechalekar, Gunnar Antoni, Wasfi Al Azzam, et al.
The Journal of Infection|March 2, 2024
Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomesGail Hayward, Ly-Mee Yu, Paul Little, et al.
The Lancet. Microbe|April 26, 2025
Immunogenicity of MVA-BN vaccine deployed as mpox prophylaxis: a prospective, single-centre, cohort study and analysis of transcriptomic predictors of responsePhilip G Drennan, Nicholas M Provine, Stephanie A Harris, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Endocrinology|June 3, 2017
Mutant Mice With Calcium-Sensing Receptor Activation Have Hyperglycemia That Is Rectified by Calcilytic TherapyValerie N Babinsky, Fadil M Hannan, Reshma D Ramracheya, et al.
The Lancet. Respiratory Medicine|July 12, 2021
Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trialTimothy S C Hinks, Lucy Cureton, Ruth Knight, et al.
BMJ Open|June 23, 2024
PERI-operative biologic DMARD management: Stoppage or COntinuation during orthoPaEdic operations (the PERISCOPE trial) - a study protocol for a pragmatic, UK multicentre, superiority randomised controlled trial with an internal pilot, economic evaluation and nested qualitative studySamantha Brady, Andrew Mott, Katie Carlisle, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|April 20, 2022
Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trialJienchi Dorward, Ly-Mee Yu, Gail Hayward, et al.
The Lancet. Respiratory Medicine|December 19, 2021
Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trialBenjamin A Fisher, Tonny Veenith, Daniel Slade, et al.
Diabetes|November 21, 2007
Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese menUlf Risérus, Dennis Sprecher, Tony Johnson, et al.
Surgery|June 29, 2021
Multiple endocrine neoplasia type 1 in children and adolescents: Clinical features and treatment outcomesOmair A Shariq, Kate E Lines, Katherine A English, et al.
BMC Cardiovascular Disorders|February 14, 2022
Pharmacodynamic evaluation and safety assessment of treatment with antibodies to serum amyloid P component in patients with cardiac amyloidosis: an open-label Phase 2 study and an adjunctive immuno-PET imaging studyAshutosh Wechalekar, Gunnar Antoni, Wasfi Al Azzam, et al.
The Journal of Infection|March 2, 2024
Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomesGail Hayward, Ly-Mee Yu, Paul Little, et al.
The Lancet. Microbe|April 26, 2025
Immunogenicity of MVA-BN vaccine deployed as mpox prophylaxis: a prospective, single-centre, cohort study and analysis of transcriptomic predictors of responsePhilip G Drennan, Nicholas M Provine, Stephanie A Harris, et al.
Pageof 4